These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39092765)

  • 21. Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER
    Ma S; Tang T; Probst G; Konradi A; Jin C; Li F; Gutkind JS; Fu XD; Guan KL
    Nat Commun; 2022 Feb; 13(1):1061. PubMed ID: 35217640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation.
    Smoot RL; Werneburg NW; Sugihara T; Hernandez MC; Yang L; Mehner C; Graham RP; Bronk SF; Truty MJ; Gores GJ
    J Cell Biochem; 2018 Jan; 119(1):824-836. PubMed ID: 28661054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma.
    Li Z; Su P; Yu M; Zhang X; Xu Y; Jia T; Yang P; Zhang C; Sun Y; Li X; Yang H; Ding Y; Zhuang T; Guo H; Zhu J
    Sci Signal; 2024 Jul; 17(843):eadk0231. PubMed ID: 38954637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.
    Conboy CB; Yonkus JA; Buckarma EH; Mun DG; Werneburg NW; Watkins RD; Alva-Ruiz R; Tomlinson JL; Guo Y; Wang J; O'Brien D; McCabe CE; Jessen E; Graham RP; Buijsman RC; Vu D; de Man J; Ilyas SI; Truty MJ; Borad M; Pandey A; Gores GJ; Smoot RL
    J Hepatol; 2023 Jan; 78(1):142-152. PubMed ID: 36162702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma.
    Tóth M; Wehling L; Thiess L; Rose F; Schmitt J; Weiler SME; Sticht C; De La Torre C; Rausch M; Albrecht T; Grabe N; Duwe L; Andersen JB; Köhler BC; Springfeld C; Mehrabi A; Kulu Y; Schirmacher P; Roessler S; Goeppert B; Breuhahn K
    BMC Cancer; 2021 Oct; 21(1):1079. PubMed ID: 34615513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.
    Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X
    Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
    Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
    Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippo signaling modulation and its biological implications in urological malignancies.
    Tong T; Huang M; Yan B; Lin B; Yu J; Teng Q; Li P; Pang J
    Mol Aspects Med; 2024 Aug; 98():101280. PubMed ID: 38870717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity.
    Sugihara T; Werneburg NW; Hernandez MC; Yang L; Kabashima A; Hirsova P; Yohanathan L; Sosa C; Truty MJ; Vasmatzis G; Gores GJ; Smoot RL
    Mol Cancer Res; 2018 Oct; 16(10):1556-1567. PubMed ID: 29903769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NEDD8 enhances Hippo signaling by mediating YAP1 neddylation.
    Chen M; Liu Y; Zuo M; Guo C; Du Y; Xu H; Liu B; Li M; Xiao W; Yu G
    J Biol Chem; 2024 Aug; 300(8):107512. PubMed ID: 38960037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors.
    Akrida I; Makrygianni M; Nikou S; Mulita F; Bravou V; Papadaki H
    Pathol Res Pract; 2024 Oct; 262():155551. PubMed ID: 39153238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
    Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
    Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.
    Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic stress dysregulates the Hippo/YAP/14-3-3η pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression.
    Zhao Y; Chen Y; Guo C; Li P; Cheng Z; Zheng L; Sha B; Xu H; Su X; Wang Y
    Theranostics; 2024; 14(9):3653-3673. PubMed ID: 38948066
    [No Abstract]   [Full Text] [Related]  

  • 35. The Hippo pathway transcription factors YAP and TAZ play HPV-type dependent roles in cervical cancer.
    Patterson MR; Cogan JA; Cassidy R; Theobald DA; Wang M; Scarth JA; Anene CA; Whitehouse A; Morgan EL; Macdonald A
    Nat Commun; 2024 Jul; 15(1):5809. PubMed ID: 38987584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bcl-2 dependent modulation of Hippo pathway in cancer cells.
    D'Aguanno S; Brignone M; Scalera S; Chiacchiarini M; Di Martile M; Valentini E; De Nicola F; Ricci A; Pelle F; Botti C; Maugeri-Saccà M; Del Bufalo D
    Cell Commun Signal; 2024 May; 22(1):277. PubMed ID: 38755629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway.
    Dong L; Lin F; Wu W; Liu Y; Huang W
    Int J Med Sci; 2018; 15(6):645-652. PubMed ID: 29725256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer.
    Yan C; Yang H; Su P; Li X; Li Z; Wang D; Zang Y; Wang T; Liu Z; Bao Z; Dong S; Zhuang T; Zhu J; Ding Y
    Oncogene; 2022 Nov; 41(48):5186-5198. PubMed ID: 36271031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two Hippo signaling modules orchestrate liver size and tumorigenesis.
    Qi S; Zhong Z; Zhu Y; Wang Y; Ma M; Wang Y; Liu X; Jin R; Jiao Z; Zhu R; Sha Z; Dang K; Liu Y; Lim DS; Mao J; Zhang L; Yu FX
    EMBO J; 2023 Jun; 42(11):e112126. PubMed ID: 36919851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RHOA activity in expanding blastocysts is essential to regulate HIPPO-YAP signaling and to maintain the trophectoderm-specific gene expression program in a ROCK/actin filament-independent manner.
    Marikawa Y; Alarcon VB
    Mol Hum Reprod; 2019 Feb; 25(2):43-60. PubMed ID: 30395288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.